Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
TECH:NASDAQ
BIO-TECHNE Corp
$54.19
+3.81%
(+1.99) 1D
$54.00
-0.35% (-0.19)
After hours
Closed: Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TECH...
Open
$52.53
High
$54.74
Low
$52.05
Mkt. cap
8.48B
Avg. vol.
2.15M
Volume
1.98M
Dividend
0.59%
Quarterly dividend
$0.08
Ex dividend date
Feb 13, 2026
P/E ratio
106.77
52-wk high
$72.16
52-wk low
$46.05
EPS
$0.51
Beta
1.49
Shares outstanding
156.45M
No. of employees
3K
News stories
From sources across the web
Profile
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. Wikipedia
About BIO-TECHNE Corp
CEOCharles R. Kummeth
Employees3.1K
Founded1976
HeadquartersMinneapolis, Minnesota, United States
SectorHealth care
Websitebio-techne.com
Last report
Feb 4, 2026
Fiscal Period
Q2 2026
Normalized EPS / Estimate
0.46/ (0.43 est.)USD
+5.84%beat
Revenue / Estimate
295.88M/ (290.47M est.)USD
+1.86%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
316.18M
316.96M
286.56M
295.88M
Cost of goods sold
101.08M
105.81M
96.36M
102.69M
Cost of revenue
101.08M
105.81M
96.36M
102.69M
Research and development expenses
21.15M
29.46M
24.24M
23.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
149.36M
66.64M
117.57M
111.87M
Operating expense
170.52M
96.10M
141.81M
134.99M
Total operating expenses
271.60M
201.92M
238.18M
237.68M
Operating income
44.58M
115.05M
48.38M
58.20M
Other non operating income
1.27M
680.00K
2.00M
-2.51M
EBT including unusual items
38.27M
-22.86M
47.99M
50.78M
EBT excluding unusual items
44.28M
116.69M
48.71M
54.52M
Income tax expense
15.69M
-5.18M
9.81M
12.78M
Effective tax rate
40.98%
22.66%
20.43%
25.16%
Other operating expenses
-
-
-
-
Net income
22.59M
-17.68M
38.18M
38.01M
Net profit margin
7.14%
-5.58%
13.33%
12.85%
Earnings per share
0.56
0.53
0.42
0.46
Interest and investment income
1.03M
585.00K
971.00K
897.00K
Interest expense
-2.01M
-2.18M
-2.93M
-2.17M
Net interest expenses
-981.00K
-1.59M
-1.96M
-1.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
72.15M
142.16M
72.72M
82.91M
Gain or loss from assets sale
-3.66M
84.16M
-6.79M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer